Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC85

Alógliptín á öllum formum sem eru vernduð af grunneinkaleyfinu

  • Status:
    Veitt
  • Application date:
    18.2.2014
  • Application published:
    15.3.2014
  • Grant published:
    15.7.2015
  • Max expiry date:
    22.9.2028
  • Next due date:
    31.12.2026
  • Medicine name:
    Vipidia
  • Medicine for children:
    No

Timeline

Today
18.2.2014Application
15.3.2014Publication
15.7.2015Registration
20.12.2026Expires

Marketing license

  • IS authorization number:
    EU/1/13/844/001-009; EU/1/13/844/010-018; EU1/13/844/019-027
  • Date:
    15.10.2013
  • Foreign authorization number:
    EU/1/13/844
  • Date:
    19.9.2013

Owner

  • Name:
    Takeda Pharmaceutical Company Limited
  • Address:
    1-1, Doshomachi 4-chome Chuo-ku, Osaka-shi,Osaka JP

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Annual fees

Number

Paid

Expires

Payer

Number: 1

Paid: 21.11.2024

Expires: 20.12.2025

Payer: Árnason Faktor ehf.

Number: 2

Paid: 15.12.2025

Expires: 20.12.2026

Payer: Árnason Faktor ehf.

Upload documents